AP
ORCL icon

Antipodes Partners’s Oracle ORCL Stock Holding History

Antipodes Partners’s Portfolio ORCL Stock Details ORCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$31.2M Sell
212,117
-27,574
-12% -$4.48M 0.6% 46
2025
Q4 		$46.7M Buy
+239,691
New +$57.1M 0.98% 37
2025
Q2 		– Sell
-282,070
Closed -$39.4M – 119
2025
Q1 		$39.4M Sell
282,070
-235,923
-46% -$38.4M 1.24% 27
2024
Q4 		$86.3M Sell
517,993
-396,159
-43% -$70.4M 3% 14
2024
Q3 		$156M Sell
914,152
-337,908
-27% -$48.9M 5.4% 4
2024
Q2 		$177M Sell
1,252,060
-387,827
-24% -$48.2M 6.42% 2
2024
Q1 		$206M Sell
1,639,887
-23,331
-1% -$2.67M 6.52% 2
2023
Q4 		$175M Sell
1,663,218
-39,058
-2% -$4.26M 5.48% 2
2023
Q3 		$181M Buy
1,702,276
+170,203
+11% +$19.7M 5.81% 2
2023
Q2 		$182M Sell
1,532,073
-385,287
-20% -$39.8M 6.3% 2
2023
Q1 		$178M Sell
1,917,360
-150,950
-7% -$13.2M 6.17% 2
2022
Q4 		$169M Sell
2,068,310
-257,451
-11% -$19.6M 6.06% 3
2022
Q3 		$142M Buy
2,325,761
+43,332
+2% +$3.17M 5.7% 3
2022
Q2 		$159M Buy
2,282,429
+267,049
+13% +$19.5M 6.64% 2
2022
Q1 		$167M Buy
2,015,380
+760,234
+61% +$61.6M 5.91% 6
2021
Q4 		$109M Sell
1,255,146
-92,764
-7% -$8.71M 3.93% 13
2021
Q3 		$117M Buy
1,347,910
+406,909
+43% +$35.9M 4.01% 11
2021
Q2 		$73.2M Buy
+941,001
New +$73.7M 2.64% 18
2019
Q1 		– Sell
-1,953,978
Closed -$88.2M – 29
2018
Q4 		$88.2M Sell
1,953,978
-171,159
-8% -$8.2M 4.36% 11
2018
Q3 		$110M Buy
2,125,137
+280,846
+15% +$13.6M 5.09% 9
2018
Q2 		$81.3M Buy
1,844,291
+75,914
+4% +$3.5M 3.86% 14
2018
Q1 		$80.9M Buy
1,768,377
+449,732
+34% +$22.4M 3.63% 14
2017
Q4 		$62.3M Buy
1,318,645
+198,854
+18% +$9.75M 3.65% 14
2017
Q3 		$53.9M Buy
+1,119,791
New +$55.7M 3.97% 13

Other funds holding ORCL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Antipodes Partners's ORCL Position: Q1 2026 in Review

Antipodes Partners reduced its Oracle (ORCL) stake by 12% in Q1 2026, selling an estimated $4.48M and leaving 212,117 shares worth $31.2M. The position accounts for 0.6% of the portfolio, ranked #46.

Antipodes Partners first reported a position in ORCL in Q3 2017 and has held it in 24 quarters since. The position peaked at $206M in Q1 2024. 3,475 funds tracked by Wall St. Rank hold ORCL as of Q1 2026.

  • Antipodes Partners held 212,117 shares of Oracle worth $31.2M as of Q1 2026.
  • Antipodes Partners sold 27,574 Oracle shares in Q1 2026, an estimated $4.48M.
  • Oracle made up 0.6% of Antipodes Partners's portfolio in Q1 2026, its #46 holding.
  • Antipodes Partners first reported a position in Oracle in Q3 2017 and has held it in 24 quarters since.
  • Antipodes Partners's Oracle position peaked at $206M in Q1 2024.
  • 3,475 funds tracked by Wall St. Rank held Oracle as of Q1 2026.

Based on Antipodes Partners's 13F filing for Q1 2026, filed 5 May 2026.